 | | | | (Reuters) - AbbVie Inc reported a better-than-expected quarterly profit on Thursday, on higher sales of its rheumatoid arthritis treatment Humira and its Hepatitis C drugs, leading the company to raise its full-year earnings forecast. | | |
| | | (Reuters) - The European Commission urged EU member states on Thursday to cooperate more closely in fighting diseases such as measles and flu, saying vaccines against them were among the most powerful and cost-effective public health measures. | | |
| | | (Reuters Health) - Women exposed to high levels of air pollution may have less success getting pregnant with fertility treatments or staying pregnant, compared to women breathing cleaner air, a South Korean study suggests. | | |
| | | LONDON (Reuters) - International scientists have identified 44 genetic variants that can increase the risk of developing major depression and found that all humans carry at least some of them. | | |
| | | (Reuters Health) - People with diabetes may have healthier blood sugar levels when they get lots of encouragement from family and friends to help them overcome the stress of managing their disease, a U.S. study suggests. | | |
| | | (Reuters Health) - When teens get extra sleep on school nights, they might cut back mostly on sedentary activities like screen time without making major changes to their exercise habits, a small experiment suggests. | | |
| | | (Reuters) - Vertex Pharmaceuticals Inc topped analysts' forecasts for quarterly profit on Thursday, led by stronger-than expected sales of its latest cystic fibrosis drug as well as double-digit growth in sales of older treatments. | | |
| | | HAMBURG (Reuters) - Germany's food industry must label unhealthy products more clearly, the country’s new agriculture and consumer protection minister said on Thursday. | | |
| | | (Reuters) - Johnson & Johnson on Wednesday secured a favorable U.S. appellate court ruling, overturning a verdict that had awarded $151 million to five people who blamed injuries they suffered on the company's Pinnacle hip implant devices. | | |
| | | ZURICH (Reuters) - Novartis's foray into digital technology intensified on Wednesday as the Swiss drugmaker launched a mobile-phone based app to help collect data from people participating in eye disease studies. | | |
|
| |
